A comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly

Clinical Drug Investigation

Volumn 19, Issue 5, 2000, Pages 317-326

  Calvo, C ^a   Gude, F ^a,m   Abellan J ^b   Olivan J ^c   Olmos, M ^d   Pita, L ^e   Sanz D ^f   Sarasa, J ^g   Bueno, J ^h   Herrera, J ⁱ   Macias J ^j   Sagastagoitia, T ^k   Ferro, B ^l   Vega, A ^l   Martinez J ^l  

^a Instituto de Salud Carlos III   (Spain)

^b Murcia S Andres Prim Care Center   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^k HOSPITAL DE BASURTO   (Spain)

^l PFIZER INC   (United States)

^m HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CREATININE; HYDROCHLOROTHIAZIDE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; GERIATRICS; HEADACHE; HEART RATE; HEMATOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCLE CRAMP; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO;

EID: 0034035186     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019050-00001     Document Type: Article

References (33)

1. 1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64
2. 2. Wilking SV, Belanger A, Kannel WB, et al. Determinants of isolated systolic hypertension. JAMA 1988; 260: 3451-5
3. 3. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8: 393-405
4. 4. Cushman WC. The clinical significance of systolic hypertension. Am J Hypertens 1998 Nov; 11 (11 Pt 2): 182-5S
5. 5. Sáez T, Suárez C, Blanco F, et al. Epidemiología de las enfermedades cardiovasculares en la población anciana española. Rev Esp Cardiol 1998; 51: 864-73
6. 6. Kannel WB, Cobb JC. Framingham Study: risk factors in the age cohort aged 65 and older. In: Lewis B, Mancini M, Farinaro E, editors. Prevention of coronary heart disease in the elderly. London: Current Medical Literature, 1990: 3-17
7. 7. Multiple Risk Factor Intervention Trial. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990; 82: 1616-28
8. 8. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598-615
9. 9. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-64
10. 10. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease: part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38
11. 11. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-83
12. 12. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-46
13. 13. Laragh JH, Brenner BM. Hypertension. New York (NY), Raven Press, 1990
14. 14. Wikstrand J, Westergren G, Berglund G, et al. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years: report from a double-blind international multicenter study. JAMA 1986; 255 (10): 1304-10
15. 15. Data on file, Pfizer International, 1990
16. 16. Machin D, Campbell MJ, Fayers PM, et al.. Sample size tables for clinical studies. 2nd ed. Oxford: Blackwell Science, 1997
17. 17. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994; 23: 275-85
18. 18. Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens 1998; 12: 575-81
19. 19. Schwartz GL, Sheps SG. A review of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Curr Opin Cardiol 1999 Mar; 14 (2): 161-8
20. 20. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-12
21. 21. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5
22. 22. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997; 278: 212-6
23. 23. Hidrosaluretil® (hidroclorotiazida D.C.I.). V-I Vademecum Internacional. 40th ed. Madrid: Medicom, S.A., 1999: 29-30
24. 24. World Health Organization Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17 (2): 151-83
25. 25. Caldwell JE. Diuretic therapy and exercise performance. Sports Med 1987; 4 (4); 290-304
26. 26. Heseltine D, Bramble MG. Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly. Curr Med Res Opin 1988; 11 (4): 232-5
27. 27. Lacourciere Y, Poirier L, Lefebvre J, et al. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension. Am J Hypertens 1995; 8 (12 Pt 1): 1154-9
28. 28. Materson BJ, Cushman WC, Goldstein G, et al. Treatment of hypertension in the elderly: I. Blood pressure and clinical changes: results of a Department of Veterans Affairs Cooperative Study. Hypertension 1990; 15: 348-60
29. 29. Pecker MS. Pathophysiologic effects and strategies for long-term diuretic treatment of hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. 1st ed. New York (NY): Raven Press, 1990: 2143-67
30. 30. Busse JC, Materson BJ. Geriatric hypertension: the growing use of calcium-channel blockers. Geriatrics 1988; 43: 51-8
31. 31. Grandinetti O, Feraco E. Middle term evaluation of amlodipine vs nitrendipine: efficacy, safety and metabolic effects in elderly hypertensive patients. Clin Exp Hypertens 1993; 15 Suppl. 1: 197-210
32. 32. Mariani L, Marino M, Cosentino N, et al. L'amlodipina nell' ipertensione sistolica isolata dell' anziano. Clin Ter 1993; 143 (1): 35-43
33. 33. Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16: 1823-9